Dr Richard Armer

Dr Richard Armer has significant experience in both biotechnology and pharmaceutical companies through his roles within Pfizer, Organon, Ardana and Oxagen over the past 13 years. Richard’s expertise is in drug discovery with a particular focus on lead optimisation activities, drug disposition and intellectual property. Throughout his career Richard has progressed through increasingly senior and broader roles within the organisations he has worked for and was most recently Director of Chemistry at Oxagen. Richard has been successful in identifying and progressing multiple clinical candidates across a wide range of therapeutic areas during his career to date.